These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20097316)

  • 21. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Update on differenciated thyroid carcinoma].
    Karayan L; Hadjadj S; Larsen CJ; Maréchaud R; Kraimps JL
    Bull Cancer; 2002 Jan; 89(1):113-23. PubMed ID: 11847033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.
    Acquaviva G; Visani M; Repaci A; Rhoden KJ; de Biase D; Pession A; Giovanni T
    Histopathology; 2018 Jan; 72(1):6-31. PubMed ID: 29239040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia.
    Caria P; Vanni R
    Cancer Genet Cytogenet; 2010 Nov; 203(1):21-9. PubMed ID: 20951315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
    Zitzelsberger H; Thomas G; Unger K
    Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signaling pathways in follicular cell-derived thyroid carcinomas (review).
    Romitti M; Ceolin L; Siqueira DR; Ferreira CV; Wajner SM; Maia AL
    Int J Oncol; 2013 Jan; 42(1):19-28. PubMed ID: 23128507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas.
    Manenti G; Pilotti S; Re FC; Della Porta G; Pierotti MA
    Eur J Cancer; 1994; 30A(7):987-93. PubMed ID: 7946598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lessons from mouse models of thyroid cancer.
    Kim CS; Zhu X
    Thyroid; 2009 Dec; 19(12):1317-31. PubMed ID: 20001715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of NF-kappaB in thyroid cancer.
    Pacifico F; Leonardi A
    Mol Cell Endocrinol; 2010 May; 321(1):29-35. PubMed ID: 19879919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms.
    Wynford-Thomas D
    Horm Res; 1997; 47(4-6):145-57. PubMed ID: 9167946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.
    Vieira JM; Santos SC; Espadinha C; Correia I; Vag T; Casalou C; Cavaco BM; Catarino AL; Dias S; Leite V
    Eur J Endocrinol; 2005 Nov; 153(5):701-9. PubMed ID: 16260429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
    Máximo V; Botelho T; Capela J; Soares P; Lima J; Taveira A; Amaro T; Barbosa AP; Preto A; Harach HR; Williams D; Sobrinho-Simões M
    Br J Cancer; 2005 May; 92(10):1892-8. PubMed ID: 15841082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid follicular oncogenesis in iodine-deficient and iodine-sufficient areas: search for alterations of the ras, met and bFGF oncogenes and of the Rb anti-oncogene.
    Bartolone L; Vermiglio F; Finocchiaro MD; Violi MA; French D; Pontecorvi A; Trimarchi F; Benvenga S
    J Endocrinol Invest; 1998 Nov; 21(10):680-7. PubMed ID: 9854684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.
    Meireles AM; Preto A; Rocha AS; Rebocho AP; Máximo V; Pereira-Castro I; Moreira S; Feijão T; Botelho T; Marques R; Trovisco V; Cirnes L; Alves C; Velho S; Soares P; Sobrinho-Simões M
    Thyroid; 2007 Aug; 17(8):707-15. PubMed ID: 17725429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of Hurthle cell neoplasms by gene profiling.
    Finley DJ; Zhu B; Fahey TJ
    Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathobiology of thyroid neoplasms.
    Tallini G
    Endocr Pathol; 2002; 13(4):271-88. PubMed ID: 12665646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.
    Pilli T; Prasad KV; Jayarama S; Pacini F; Prabhakar BS
    Thyroid; 2009 Dec; 19(12):1333-42. PubMed ID: 20001716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
    Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular and genetic markers of follicular-cell thyroid cancer: etiology and diagnostic and therapeutic opportunities.
    Goyal N; Setabutr D; Abdulghani J; Goldenberg D
    Adv Exp Med Biol; 2013; 779():309-26. PubMed ID: 23288646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.